Topiramate-induced bilateral central serous chorioretinopathy

Arq Bras Oftalmol. 2022 Nov 4;85(6):652-653. doi: 10.5935/0004-2749.2022-0243. eCollection 2022.

Authors

Alparslan Şahin¹, Fatih Mehmet Türkcü¹, Yasin Çınar²

Affiliations

¹ Private Bower Hospital, Department of Ophthalmology, Diyarbakir, Turkey.
² Department of Ophthalmology, School of Medicine, Dicle University Diyarbakir, Turkey.

PMID: 36350931
DOI: 10.5935/0004-2749.2022-0243

No abstract available

Publication types

Letter

MeSH terms

Central Serous Chorioretinopathy* / chemically induced
Central Serous Chorioretinopathy* / diagnostic imaging
Fluorescein Angiography
Humans
Tomography, Optical Coherence
Topiramate / adverse effects

Substances

Topiramate